Navigation Links
STAAR Surgical Reports 19% Revenue Growth Second Quarter
Date:8/2/2011

0;In our top 10 targeted markets the Visian ICL grew by 48% with six of ten markets growing more than 48%."

"The gross profit margin in the quarter of 66.8% represents a 320 basis point improvement over the second quarter last year and reflects a stronger mix toward higher margin ICL and IOL sales," continued Mr. Caldwell. "I want to thank our employees at STAAR as we challenged them with some stretch objectives and they have responded with a terrific quarter and first half of 2011.  With $13.1 million of cash at the end of the quarter combined with generating cash from operations, we feel very comfortable we can fund current growth plans from our operating cash flow."

"With the regulatory approvals received during the first half of the year and positive momentum, we are poised for continued strong growth during the second half of 2011.  We are on track with our plans to launch four new products in the second half of the year in countries where we have received approvals.  The new Visian ICL with the CentraFLOW™ proprietary technology is currently in limited marketing release and will be fully launched to the European markets at the ESCRS meeting in September.  The CentraFLOW technology utilizes the KS-AquaPORT™ to restore the natural flow within the eye.  This allows for the elimination of a step which typically requires an additional procedure and visit to the surgeon's office.  We believe this will have a significant impact on  surgeon use and adoption of the Visian ICL."

"Our successful execution has bolstered our confidence in the outlook, and as a result we are raising three of four key metric targets for fiscal 2011.  We continue to expect double-digit growth in revenue, but have increased our target for ICL sales growth from 25% to 30%.  We expect continued expansion of our gross margin and now anticipate it will reach 66.5% for the full year.  Finally, we believe that we will
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000
2. STAAR Surgicals nanoFLEX™ Collamer® IOL Receives CE Mark Approval
3. STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign
4. STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia
5. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
6. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
7. STAAR Surgical Reports Continued Double Digit Core Revenue Growth
8. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
9. STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
10. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
11. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... the Patent Trial and Appeals Board (PTAB) in response ... filed by a unit of Boston Scientific Corporation, challenging ... 8,359,102 (the ,102 patent). The ,102 patent is one of Nevro,s 55 ...
(Date:9/1/2015)... Sept. 1, 2015 Ardelyx, Inc. (NASDAQ: ... on gastrointestinal and cardio-renal diseases, today announced that ... option and license agreement for Ardelyx,s portfolio of ... no payment associated with termination and the return ... and Sanofi entered into an option and license ...
(Date:9/1/2015)... Sept. 1, 2015 NOWDiagnostics Inc., based in ... Corporation of Canada , a move ... a world where people have greater access to information ... a line of unique blood-based rapid tests that allow ... for a variety of ailments and diseases. ZBx Corporation, ...
Breaking Medicine Technology:Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3
(Date:9/1/2015)... Fairfax, VA (PRWEB) , ... September 01, 2015 ... ... the Mane Vendor “Hair Extension Vending Machine,” is still strongly maintaining her firm’s ... modern technology, and beauty tools. In her upcoming city-to-city tour, Ellis will be ...
(Date:9/1/2015)... ... September 01, 2015 , ... The ... Information Management has been granted continued accreditation based on a successfully completed ... “Achieving and maintaining this accreditation takes the involvement and dedication of each ...
(Date:9/1/2015)... ... 01, 2015 , ... With former IBMers among its founding members, Inmar has ... more than 35 years ago. A pilot program begun by the company in 2014 ... just those intent on pursuing careers in these fields. The program is now open ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Royal River Natural ... study that followed men and women for 19 years and found that, among those ... not take multivitamins. , The report is part of the September 2015 issue of ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... The ... and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of a collection ... same mission – to raise awareness of the FSH Society and further FSHD research. ...
Breaking Medicine News(10 mins):Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3
... Feb. 24 drugstore.com , inc. (Nasdaq: ... of health, beauty, vision, and pharmacy products, today ... be presenting at the upcoming Jefferies 5th Annual ... drugstore.com(TM) presentation will take place on Thursday, February ...
... 24 PolyRemedy, Inc., a,manufacturer of point-of-care robotic ... wound treatments, has hired Jeffrey S.,Jones to serve ... Jones, a,seasoned healthcare executive, joined the PolyRemedy management ... "With his experience in growing innovative medical device ...
... New guidelines suggest that men discuss use of medicines such ... News) -- Healthy men with no signs of prostate cancer ... drug that could further reduce their risk for the disease, ... Oncology and the American Urological Association have issued new guidelines ...
... danger, large study finds, , , TUESDAY, Feb. 24 (HealthDay News) ... that even moderate drinking raises risks for breast, liver and ... on the order of one alcoholic drink per day -- ... Naomi Allen, from the cancer epidemiology unit at the University ...
... would Lower the Standard of Care by Allowing ... Anesthesia to Maryland PatientsANNAPOLIS, Md., Feb. 24 ... members are Certified Registered Nurse Anesthetists (CRNAs), today ... House Bill 1161. These troubling bills would ...
... RIVER EDGE, N.J., Feb. 24 ... device company developing and marketing filtration products for ... reported that is has received initial responses from ... for dialysis devices. 510k Application for OLpur ...
Cached Medicine News:Health News:drugstore.com, inc. to Present at the Upcoming Jefferies 5th Annual Internet & Media Conference 2Health News:PolyRemedy Names Jeffrey Jones as Its Chief Operating Officer 2Health News:Drugs May Help Healthy Men Lower Prostate Cancer Risk 2Health News:Drinking Raises Cancer Risk for Middle-Age Women 2Health News:Drinking Raises Cancer Risk for Middle-Age Women 3Health News:New Anesthesia Provider May Threaten Operating Room Safety 2Health News:New Anesthesia Provider May Threaten Operating Room Safety 3Health News:New Anesthesia Provider May Threaten Operating Room Safety 4Health News:Nephros Provides Update on 510k Applications 2Health News:Nephros Provides Update on 510k Applications 3Health News:Nephros Provides Update on 510k Applications 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: